Dr. Brian Bressler speaks with Dr. Neeraj Narula and Dr. Cynthia Seow about JAK inhibitor safety and efficacy in 2025. This episode of Science for the Real World is part of <a href="https://canadianibdtoday.com/" target="_blank">⁠Canadian IBD Today⁠</a>, an open access scientific journal for the gastroenterology community.

Dr. Brian Bressler speaks with Dr. Neeraj Narula and Dr. Cynthia Seow about JAK inhibitor safety and efficacy in 2025. This episode of Science for the Real World is part of ⁠Canadian IBD Today⁠, an open access scientific journal for the gastroenterology community.

Dr. Brian Bressler speaks with Dr. Neeraj Narula and Dr. Cynthia Seow about JAK inhibitor safety and efficacy in 2025. This episode of&nbsp;Science for the Real World&nbsp;is part of&nbsp;<a href="https://canadianibdtoday.com/" rel="noopener noreferrer">⁠Canadian IBD Today⁠</a>, an open access scientific journal for the gastroenterology community.

JAK Inhibitor Safety and Efficacy in 2025

The aim of Canadian IBD Today is to provide perspective and insight on the management of common diseases and disorders in IBD and to provide a forum for clinicians to share their real-world experiences in practice.

Share JAK Inhibitor Safety and Efficacy in 2025

Sign up to save your podcasts

JAK Inhibitor Safety and Efficacy in 2025

JAK Inhibitor Safety and Efficacy in 2025